Jan 24, 2012

A clinical trial deals with the application of specific clinical or
scientific methods or medicine to the human body. Clinical trials are
used to identify the effect of particular treatment or medication on
patients suffering from a particular disease. The process of a clinical
trial starts with identification of the medication or medical device to
be tested. Participants for the trial are selected and the results are
studied in order to define the effectiveness of the drug or device.

Clinical
trials are very crucial as they involve huge capital investment and may
affect the subjects involved. Thus proper management of clinical trials
has become a priority for the hospitals. Clinical Trial Management
System (CTMS) is a software system employed to manage the large amounts
of data involved in a clinical trial. It maintains the planning,
preparation, performance, and reporting of clinical trials, including
participant information, trial and filing deadlines and other important
milestones. The global CTMS market was valued at $576.22 million in
2010.

Improved clinical trial efficiency with optimized process;
centralized database; improved site performance by enhanced investigator
relationships; higher subject accrual rate & reduced workload for
research coordinators; efficiency in budgeting and financial management;
improved cost efficiencies; improved clinical research associate
productivity; and automated data processing and report generating are
some of the key advantages of CTMS that are driving the market.

Clinical
Trial Management System (CTMS) is used by the clinical trial
organizations such as Pharmaceutical/Biopharmaceutical Companies,
Clinical Research Organizations (CROs), and Healthcare providers
(Hospitals, Academic Medical Centers (AMCs) which handle clinical trial.
The pharmaceutical CTMS market contributed the largest share; i.e. 49%
in 2010. Clinical Research Organizations (CRO) and Healthcare providers
contributes 46% and 5% respectively in 2010.

Based on the mode of
delivery, the CTMS market is divided into three types; i.e. web-based
CTMS, on-Premise CTMS, and cloud-based CTMS. Among all these segments,
the web-based market is forecasted to witness the highest CAGR of 15.95%
from 2011 to 2016 and is estimated to capture 75% share by 2016 from
70% share in 2010. On-premise CTMS and cloud-based (SAAS) CTMS
contributes 28% and 2% respectively in 2010.

North America
dominated the global CTMS market with around 62% share in 2010. The U.S.
captures the largest market share of North America, and shows a
remarkable growth opportunity. The second largest market, Europe, while
growth in the Asia-Pacific region is also expected to take greater
curves in the near future.

Scope of the Report

This
Clinical Trial Management System (CTMS) market research report will
enable strategic understanding of the following key segments of the
market:

Each
section of the report offers market data for the various market
segments and geographies. It also provides market trends with respect to
drivers, restraints, and opportunities. The report’s “strategy” section
sketches the competitive landscape with about four company profiles.